Pneumonia Vaccine Market Size, Share, Trends Report 2031
Precision Business Insights has published a report on the global pneumonia vaccine market, estimating its value at USD 10.35 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/global-pneumonia-vaccine-market
The pneumonia vaccine market includes vaccinations that prevent pneumococcal infections, namely those caused by Streptococcus pneumoniae. These vaccinations—primarily pneumococcal conjugate vaccines (PCVs) and pneumococcal polysaccharide vaccines (PPSVs)—are given to newborns, children, the elderly, and immunocompromised people.
Drivers:
- High susceptibility among elderly individuals drives adult vaccination programs, especially in North America and Europe.
- Rising healthcare budgets and urban demand in Asia-Pacific fuel rapid market expansion.
The global pneumonia vaccine market segmentation:
1) By Product Type: Prevnar 13, Synflorix, and Pneumovax 23
2) By Dosage: Single Dose Vial and Pre-filled Syringe
3) By End User: Child, Adult and Geriatric
4) By Vaccine Type: Pneumococcal Conjugate Vaccine, and Pneumococcal Polysaccharide Vaccine
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=46307
Regional Overview:
The report also examines the current concerns and their Future Effects on the pneumonia vaccine market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the pneumonia vaccine market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
The competitive landscape is dominated by major players like GlaxoSmithKline plc, Pfizer Inc, CSL Ltd, Merck & Co., Inc., Serum Institute of India Pvt. Ltd, Sanofi Pasteur Inc.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian